Xilio Therapeutics (XLO) Prepaid Assets (2020 - 2026)

Xilio Therapeutics has disclosed Prepaid Assets across 7 years of filings, most recently posting $3.9 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $3.9 million, down 6.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 6.13% YoY), and the FY2025 annual result was $2.5 million, down 49.5% from the prior year.
• Prepaid Assets came in at $3.9 million for Q1 2026 at Xilio Therapeutics, up from $2.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $5.2 million in Q1 2024 to a low of $2.0 million in Q3 2024.
• The 5-year median for Prepaid Assets is $3.6 million (2022), against an average of $3.6 million.
• Across the five-year window, Prepaid Assets surged 48.47% in 2023 and tumbled 56.46% in 2024, its largest moves.
• Xilio Therapeutics' Prepaid Assets stood at $4.1 million in 2022, then fell by 16.74% to $3.4 million in 2023, then surged by 44.41% to $4.9 million in 2024, then plunged by 49.5% to $2.5 million in 2025, then jumped by 55.21% to $3.9 million in 2026.
• The last three Prepaid Assets figures came in at $3.9 million (Q1 2026), $2.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.